An Economic Evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK Setting

Journal of Human Hypertension - United Kingdom
doi 10.1038/sj.jhh.1001729
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Protective Effects of Irbesartan and Alpha Lipoic Acid in STZ-induced Diabetic Nephropathy in Rats

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2010English

The Case | Diabetic Nephropathy in a Nondiabetic Smoker?

Kidney International
Nephrology
2012English

Autophagy in Diabetic Nephropathy

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Evaluation of Serum Obestatin Level in Rat Model of Diabetic Nephropathy

The Medical Journal of Cairo University
2018English

An Economic Evaluation Alongside a Clinical Trial (EEACT) in Pelvic Floor Medicine

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Update in Diabetic Nephropathy

International Journal of Diabetes and Metabolism
2005English

Prognosis in Diabetic Nephropathy.

British Medical Journal
1989English

Inhibition of RAS in Diabetic Nephropathy

International Journal of Nephrology and Renovascular Disease
Nephrology
2015English

Oxidative Stress in Diabetic Nephropathy

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy